Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Matthew Jenusaitis Insider Profile
11 Followers
Matthew Jenusaitis, Director at enVVeno Medical, holds 16.55K shares in enVVeno Medical (Ticker: NVNO). Most recently, Matthew Jenusaitis Bought $9,620 shares of enVVeno Medical on Dec 23, 2024 for an estimated value of 24.34K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+3.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Matthew Jenusaitis's holdings
Insider Roles
Director
Roles that Matthew Jenusaitis holds in companies
Most Profitable Insider Trade
The most profitable trade made by Matthew Jenusaitis
Matthew Jenusaitis's Trading History
List of latest transactions for each holding click on a transaction to see Matthew Jenusaitis's performance on stock
You May Also Like
Matthew Jenusaitis insider profile FAQ
What is the percentage of profitable transactions made by Matthew Jenusaitis?
The percentage of profitable transactions made by Matthew Jenusaitis is 50%.
What is the average return per transaction made by Matthew Jenusaitis?
The average return per transaction made by Matthew Jenusaitis is 3.70%.
What stocks does Matthew Jenusaitis hold?
Matthew Jenusaitis holds: NVNO stocks.
What was Matthew Jenusaitis’s latest transaction?
Matthew Jenusaitis latest transaction was an Informative Buy of $24.34K.
What was Matthew Jenusaitis's most profitable transaction?
Matthew Jenusaitis’s most profitable transaction was an Informative Buy of NVNO stock on December 23, 2024. The return on the trade was 16.10%.
What is Matthew Jenusaitis's role in enVVeno Medical?
Matthew Jenusaitis's role in enVVeno Medical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.